Clinical trials
Alzheimer Disease trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
127 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 11 |
| 2008 | 7 |
| 2009 | 10 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 74 |
| Terminated | 29 |
| Recruiting | 12 |
| Active, not recruiting | 7 |
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 12 |
| Hoffmann-La Roche | 11 |
| Karolinska Institutet | 8 |
| AstraZeneca | 7 |
| GlaxoSmithKline | 7 |
| Eli Lilly and Company | 6 |
| Janssen Research & Development, LLC | 6 |
| Novartis Pharmaceuticals | 5 |
| Skane University Hospital | 5 |
| Biogen | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 127 |
| Dementia | 22 |
| Cognitive Dysfunction | 21 |
| Neurodegenerative Diseases | 8 |
| Central Nervous System Diseases | 7 |
| Amyloid Neuropathies, Familial | 6 |
| Brain Diseases | 6 |
| Amyloidosis | 5 |
| Cognition Disorders | 4 |
| Lewy Body Disease | 4 |
Trials
Showing 51 to 75 of 127. Each trial links to its page on Pharma Observatory.
27 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.